Integrative bioinformatics and experimental analysis revealed down-regulated CDC42EP3 as a novel prognostic target for ovarian cancer and its roles in immune infiltration
Ovarian cancer is a significant clinical challenge as no effective treatments are available to enhance patient survival. Recently, N6-methyladenosine (m6A) RNA modification has been demonstrated to play a pivotal role in tumorigenesis and progression. However, the roles of m6A target genes in ovaria...
Main Authors: | Yuanliang Yan, Qiuju Liang, Zhijie Xu, Qiaoli Yi |
---|---|
Format: | Article |
Language: | English |
Published: |
PeerJ Inc.
2021-09-01
|
Series: | PeerJ |
Subjects: | |
Online Access: | https://peerj.com/articles/12171.pdf |
Similar Items
-
CDC42—A promising immune-related target in glioma
by: Tao Jiang, et al.
Published: (2023-07-01) -
Lipidation of small GTPase Cdc42 as regulator of its physiological and pathophysiological functions
by: Alexander Wirth, et al.
Published: (2023-01-01) -
The role of Cdc42 and Gic1 in the regulation of septin filament formation and dissociation
by: Yashar Sadian, et al.
Published: (2013-11-01) -
Cell division cycle 42 effector protein 4 inhibits prostate cancer progression by suppressing ERK signaling pathway
by: Xiaowen Zhang, et al.
Published: (2023-12-01) -
miR-185-5p Regulates Inflammation and Phagocytosis through CDC42/JNK Pathway in Macrophages
by: Xirui Ma, et al.
Published: (2022-03-01)